Figure 2.
The frequency (A) and number (B) of regulatory T cells in recipients of AzaC (n = 8 patients) compared to control (CNTL) (n = 3 patients).
The frequency (A) and number (B) of regulatory T cells in recipients of AzaC (n = 8 patients) compared to control (CNTL) (n = 3 patients).